GDNF and Parkinson disease: Delivery of GDNF or GDNF family ligands (GFLs) to the striatum protects, regenerates, and improves the metabolism of substantia nigra pars compacta neurons (SNpc), a key neuronal population degenerating during PD pathogenesis [1–6], resulting in amelioration of motor deficits in PD models.